Par Pharmaceutical Cos. Inc. (PRX) Stock Quote

Detailed Quote for Par Pharmaceutical Cos. Inc. (PRX)

After Hours: $ 38.00

0.00 (0.00%)

Volume: 1.97 k

4:26 PM EST Feb 3, 2012

close 52 Week Information

52 Week High

February 3, 2012

Close: 38.85

52 Week Low

September 22, 2011

Close: 24.85

Today

Last Price
38.00

Change $
0.30

Change %
0.80%

Tick
N/A

Bid
34.49

Bid Size
100

Ask
N/A

Ask Size
0

Open
38.00

High
38.85

Low
37.92

Prev Close
37.70

Last Trade
4:03

Volume
377.04 k

52 Wk Hi
38.85

52 Wk Low
24.85

Market Cap
1.39 b

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
36,482,469

EPS (TTM)
-1.74

PE Ratio
N/A

close Exchange Information Listed On New York Stock Exchange (NYE) Exchange
NYE

News and Media for Par Pharmaceutical Cos. Inc. (PRX)

Sector News | Topic News

News for PRX

Tue, Jan 31, 2012

9:00 AM

Par Pharmaceutical Companies to Report Fourth Quarter and Full Year 2011 Results on February 28, 2012 - PR Newswire

Wed, Dec 21, 2011

6:00 AM

IntelGenx Announces Development and Commercialization Agreement with Par Pharmaceutical, Inc. - Newsfile

Mon, Dec 05, 2011

9:37 AM

Par Pharmaceutical to Host Analyst Day on January 6, 2012 - PR Newswire

Tue, Nov 22, 2011

8:30 AM

Par Pharmaceutical Companies Promotes Thomas J. Haughey to President and Paul V. Campanelli to Chief Operating Officer - PR Newswire

Thu, Nov 17, 2011

12:45 PM

Par Pharmaceutical Completes Acquisition of Anchen - PR Newswire

Wed, Nov 02, 2011

7:30 AM

Par Pharmaceutical Companies Reports Third Quarter 2011 Results - PR Newswire

Mon, Oct 24, 2011

3:34 PM

Par Pharmaceutical Begins Shipment of Generic Zyprexa® Zydis® - PR Newswire

Tue, Oct 18, 2011

9:00 AM

Par Pharmaceutical Acquires Three Generic Products From Teva Pharmaceuticals - PR Newswire

Fri, Oct 14, 2011

4:15 PM

Par Pharmaceutical Files Declaratory Judgment to Protect First Amendment Rights to Disseminate Truthful Information Regarding Megace® ES - PR Newswire

Fri, Oct 07, 2011

9:00 AM

Expert's Economic Outlook, Global - Equity Research on Par Pharmaceutical Companies, Inc. and Targacept, Inc. - Marketwire

Mon, Oct 03, 2011

4:15 PM

Par Pharmaceutical Companies to Report Third Quarter 2011 Results on November 2, 2011 - PR Newswire

9:00 AM

Global Situation & Resulting Influences - Research Report on Akorn, Inc. and Par Pharmaceutical Companies, Inc. - Marketwire

Mon, Aug 22, 2011

9:55 AM

The Zacks Analyst Blog Highlights: Par Pharmaceutical Companies, Intellipharmaceutics International, Celgene Corporation, Novartis AG and Elan Corporation plc - PR Newswire

More News for PRX >>

Tags for Par Pharmaceutical Cos. Inc.

Research stocks or mutual funds related to Par Pharmaceutical Cos. Inc. by keywords or tags. Find companies that have a similar focus to PRX. The keywords below have been associated to PRX by either user submission or electronic means.

biotechnology company phat farms shoe biotech research pharm sales doxycycline capsules pharmaceutical branding phat farm trainers biotechnology industry news pharm tech jobs pharmaceutical publication biotech conference pharmaceutical market generic pharmaceutical prostate treatment advanced prostate cancer phat farm shirts pharm eu biotechnology market pharmaceutical research and development phat farm footwear baby phat scarf new phat farm pharmaceutical manufacturing company phat baby shoes prostate biopsy baby phat farm phat farms cancer prostate phat farm jackets pharma manufacturing phat farm shoes pharm d pharma license pharmaceutical supply chain par pharma novartis pharmaceuticals gmp pharmaceutical cv therapeutics pharmaceutical cro phat farm jeans pharmaceutical sales pharmaceutical conferences pharm d degree pharmaceutical distributors hydroquinone usp 4 protox therapeutics liver cancer biotech corporation pharmaceutical reports skin cancer